glp 1 news today Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists GLP-1 Pipeline Update: November 2025

It was approved by the FDA under the trade name Adlyxin in 2016 and launched in China in January 2018

Cerezyme was originally approved in 1994

The problem comes when compounding is exploited as a loophole

These broader changes could have a wide-ranging impact on companies across numerous sectors including healthcare, pharmaceuticals, insurers, medical device companies, the food and beverage industry, retailers, fitness businesses, airlines and many more

10.2337/dc12-2504 [DOI] [PMC free article] [PubMed] [Google Scholar] 46.Meier JJ, Nauck MA

Since the kidneys play a key role in processing these medications, adjusting the dosage to match a patients kidney function helps reduce the risk of side effects while enhancing benefits like better blood sugar management and kidney health support